KT-253
kymera therapeutics
['leukemia', '$kymr', 'kymera ']
$kymr kymera therapeutics presents data demonstrating superior efficacy of kt-253, a potent and selective heterobifunctional mdm2 degrader, compared to small molecule inhibitor in preclinical leukemia models at the european hematology association congress 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities